Alzex Neuropharma Inc.

TRRI

US89656L1035

Investment Holding Companies

Market Closed - OTC Markets Other stock markets 07:09:59 09/05/2024 pm IST			5-day change	1st Jan Change
0.1 ^USD	0.00%		0.00%	-50.00%

2015	Trinity Resources Inc. will Change its Ticker to TRRI from TRLR.D	CI
2013	Trulan Resources Inc. to Acquire Additional Property Around its Existing IGP Iron-Gold-Platinum Project in Chile	CI

Trulan Resources Inc. Signs Definitive Agreement to Acquire the IGP Iron-Gold-Platinum Project in Chile's Region IV

February 28, 2013 at 09:27 pm IST

Trulan Resources Inc. has signed a definitive agreement to acquire the IGP iron-gold-platinum project in Chile's region IV.

Latest news about Alzex Neuropharma Inc.

Trinity Resources Inc. will Change its Ticker to TRRI from TRLR.D	22/15/22	CI
Trulan Resources Inc. to Acquire Additional Property Around its Existing IGP Iron-Gold-Platinum Project in Chile	29/13/29	CI
Trulan Resources Inc. Reports 1,905,428 Ounces of Platinum Indicated Within Four Zones on the IGP Iron-Gold-Platinum Project in Chile	28/13/28	CI
Trulan Resources Inc. Establishes Wholly Owned Subsidiary And Corporate Office in Santiago, Chile	28/13/28	CI
Trulan Resources Inc. Begins Process of Incorporating Wholly Owned Subsidiary in Chile, South America	13/13/13	CI
Trulan Resources Inc. Signs Definitive Agreement to Acquire the IGP Iron-Gold-Platinum Project in Chile's Region IV	28/13/28	CI
Trulan Resources Inc. Receives Necessary Due Diligence Information on Iron, Gold, Platinum and Industrial Mineral Project Acquisition	25/13/25	CI
Trulan Signs Letter of Intent to Acquire Iron, Gold, Platinum and High Value Industrial Mineral Deposits	23/13/23	CI
Trulan Resources Inc. will Change its Ticker to TLAN from TLAN.D	17/12/17	CI
Hire International, Inc. Appoints Chris Beck as CEO to Replace Jeremy Stobie	09/12/09	CI

Alzex Neuropharma Inc., formerly Trinity Resources Inc., is a biopharmaceutical company. The Company is engaged in research and development targeting treatments of brain diseases. It is also focused on chemical development of its new drugs dedicated to the symptomatic treatment of Alzheimerâs Disease but can be applied to other neurological diseases due to its platform technology.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
ALZEX NEUROPHARMA INC.	-50.00%	151K
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+191.37%	6.97B
SCREAMING EAGLE ACQUISITION CORP.	+5.09%	1.04B
CHURCHILL CAPITAL CORP VII	+2.10%	982M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+24.45%	814M
E7 GROUP	+11.31%	675M
ARES ACQUISITION CORPORATION II	+1.72%	664M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ADMIRAL ACQUISITION LIMITED	+3.61%	503M

Shell Companies

Alzex Neuropharma Inc.

Equities

TRRI

US89656L1035

Investment Holding Companies

Trulan Resources Inc. Signs Definitive Agreement to Acquire the IGP Iron-Gold-Platinum Project in Chile's Region IV

Latest news about Alzex Neuropharma Inc.

Chart Alzex Neuropharma Inc.

Company Profile

Sector Shell Companies